The Early Bactericidal Activity of High-Dose or Standard-Dose Isoniazid Among Adult Participants With Isoniazid-Resistant or Drug-Sensitive Tuberculosis
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Isoniazid (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 11 Aug 2021 Biomarkers information updated
- 05 Dec 2013 Planned initiation date changed from 1 Sep 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 05 Dec 2013 Planned end date changed from 1 Jul 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov.